Shock: Clinical Trials

72 trials for Shock, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

72 completed. 72 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 472Completed 72

Follow Shock: new trials by email Literature Review of Shock trials Research Report on Shock

Trials (filtered) newest first · largest first

All 72 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Continuous Infusion Versus Intermittent Bolus Hydrocortisone in Septic Shock
Hydrocortisone Continuous Infusion, Hydrocortisone Intermittent Bolus - Septic Shock
Phase 4CompletedBenha University1102026-01-012026-07-10
Vasopressin for Septic Shock Pragmatic Trial
Vasopressin, Recommendation to use a lower initiation threshold for vasopressin, Recommendation to use a higher initiation threshold for vasopressin - Septic Shock
Phase 4CompletedIntermountain Health Care, Inc.39592024-02-012026-08-03
Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock
Angiotensin II - Septic Shock, Vasodilatory Shock
Phase 4CompletedUniversity of New Mexico422023-04-172026-07-02
Hypotension in the Weaning From Vasopressor Drugs
Norepinephrine, Vasopressin - Septic Shock
Phase 4CompletedHospital Nossa Senhora da Conceicao782022-05-012025-03-14
Vitamin C Deficiency in Septic Shock
Ascorbic acid - Septic Shock
Phase 4CompletedCairo University1502021-12-012024-01-25
Midodrine for the Early Liberation of Vasopressor Support in the ICU
Midodrine, Placebo - Critical Illness, Shock
Phase 4CompletedUniversity of Alberta202021-03-222023-10-06
Heamodynamic Effects of Paracetamol in Septic Shock Patients
Paracetamol, Normal saline - Septic Shock, Sepsis
Phase 4CompletedAyah Mohammed Khalil612020-11-012023-10-12
Renin and Renal Biomarker Response to Angiotensin II
Standard of Care, Angiotensin II - Septic Shock, Acute Kidney Injury
Phase 4CompletedAlexander Flannery302020-10-192024-09-04
Angiotensin II in the Perioperative Management of Hypotension in Kidney Transplant Recipients
Angiotensin II - Shock, Surgical, Shock
Phase 4CompletedUniversity of Illinois at Chicago202020-08-132022-12-21
Fluoxetine to Reduce Intubation and Death After COVID19 Infection
Fluoxetine - COVID-19, Cytokine Storm
Phase 4CompletedUniversity of Toledo Health Science Campus162020-05-012024-06-07
Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP)
Comparison 1: Prehospital Ceftriaxone, Comparison 1: Placebo, Comparison 2: Liberal fluids - Severe Sepsis or Septic Shock
Phase 4CompletedDr. Damon Scales20612020-03-232026-04-20
The Effect of Restrictive Fluid Management on Cardiac Function and Glycocalyx Degradation
I.V. SOLUTIONS - Septic Shock
Phase 4CompletedKarolinska Institutet542020-02-022025-04-03
Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock
Vasopressor Agent, Crystalloid Solutions, Invasive Blood Pressure Monitoring - Septic Shock, Septicemia
Phase 4CompletedBozyaka Training and Research Hospital852019-12-022022-11-29
Evaluation of Corticosteroid in Systemic Inflammatory Response Syndrome
solumedrol, Dexamethasone phosphate - Systemic Inflammatory Response Syndrome
Phase 4CompletedAssiut University602019-09-012021-06-14
Blessing or Curse? Combined Vitamin Therapy in Non Viral Septic Shock.
Vitamin C - Septic Shock
Phase 4CompletedUniversity of Pecs432019-01-012023-11-30
Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)
Simultaneous CRRT, Conventional-indication CRRT, Esmolol - Cardiogenic Shock
Phase 4CompletedBeijing Anzhen Hospital1312018-12-182024-04-24
GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study
GM-CSF - Pediatric Sepsis-induced MODS
Phase 4CompletedNationwide Children's Hospital752018-12-052026-05-05
The Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Trial
Isotonic crystalloids - Septic Shock
Phase 4CompletedAnders Perner, MD, PhD15542018-11-272025-02-24
Evaluation of the Role of Hydrocortisone Either Alone or Combined With Fludrocortisone in the Outcome of Septic Shock in Adults
Hydrocortisone - Septic Shock
Phase 4CompletedAin Shams University662018-09-012020-07-30
Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
Cangrelor, Ticagrelor - Acute Myocardial Infarction, Cardiogenic Shock
Phase 4CompletedFaculty Hospital Kralovske Vinohrady6052018-08-012025-04-02

Showing 20 of 72. Sign in to see all of them.

Narrower conditions

Shock, Septic (38)  ·  Sepsis (21)  ·  Systemic Inflammatory Response Syndrome (13)  ·  Shock, Cardiogenic (10)  ·  Multiple Organ Failure (5)  ·  Myocardial Infarction (4)  ·  Critical Illness (3)  ·  Acute Kidney Injury (2)  ·  Bacteremia (2)  ·  Diabetes Insipidus (2)  ·  Gram-Negative Bacterial Infections (2)  ·  Acute Coronary Syndrome (1)  ·  Acute Lung Injury (1)  ·  Adrenal Insufficiency (1)

Broader conditions

Pathologic Processes (72)  ·  Pathological Conditions, Signs and Symptoms (72)  ·  Inflammation (52)  ·  Infections (43)  ·  Systemic Inflammatory Response Syndrome (40)  ·  Sepsis (21)  ·  Cardiovascular Diseases (17)  ·  Vascular Diseases (14)  ·  Heart Diseases (12)  ·  Ischemia (10)  ·  Myocardial Ischemia (10)  ·  Necrosis (10)  ·  Infarction (9)  ·  Myocardial Infarction (6)

Interventions

Hydrocortisone (4)  ·  Angiotensin II (3)  ·  Ascorbic Acid (3)  ·  Norepinephrine (3)  ·  Saline Solution (3)  ·  Sodium Chloride (3)  ·  hydrocortisone hemisuccinate (3)  ·  Albumins (2)  ·  Crystalloid Solutions (2)  ·  Dexamethasone (2)  ·  Fentanyl (2)  ·  Intra-Aortic Balloon Pumping (2)  ·  Midazolam (2)  ·  Midodrine (2)  ·  Propofol (2)

Sponsors

Ain Shams University (3)  ·  Amsterdam UMC, location VUmc (2)  ·  Cairo University (2)  ·  Central Hospital, Nancy, France (2)  ·  Charles University, Czech Republic (2)  ·  Karolinska Institutet (2)  ·  Southeast University, China (2)  ·  Sutep Jaruratanasirikul (2)  ·  Alexander Flannery (1)  ·  Anders Perner (1)  ·  Anders Perner, MD, PhD (1)  ·  Assiut University (1)  ·  Association Niçoise de Réanimation Médicale (1)  ·  Association pour le Développement de la Recherche et de l'Enseignement en Médecine d'Urgence (1)  ·  Ayah Mohammed Khalil (1)

Countries

France (10)  ·  Germany (8)  ·  United States (8)  ·  Egypt (7)  ·  Canada (5)  ·  China (5)  ·  Denmark (5)  ·  Brazil (4)  ·  Czechia (4)  ·  Netherlands (4)  ·  Sweden (4)  ·  Italy (3)  ·  Australia (2)  ·  Belgium (2)  ·  Finland (2)

Top investigators

Holger Thiele, MD (2)  ·  Ahmed Mukhtar (1)  ·  Alaa F Fathy, researcher (1)  ·  Alessandro Pontes-Arruda, MD, PhD (1)  ·  Alexander H Flannery, Pharm.D. (1)  ·  Anders Perner, MD PhD (1)  ·  Andrzej Okreglicki, MD (1)  ·  Angel Arenal, MD (1)  ·  Balasubramanian Venkatesh (1)  ·  Benjamin M Hibbert, MD, PhD (1)  ·  Bernd Lemke, MD (1)  ·  Bin Du, MD (1)

Results publications

PMID 33647946, PMID 11529214, PMID 11588440, PMID 12500513, PMID 12519925, PMID 15343008, PMID 16134766, PMID 16879732, PMID 18305265, PMID 19007597, PMID 19068113, PMID 19175450, PMID 19318651, PMID 19531784, PMID 19926252, PMID 19958532, PMID 20109575, PMID 20725823, PMID 21526919, PMID 21926570, PMID 21960699, PMID 22488003, PMID 22518026, PMID 22920912, PMID 23006898, PMID 23288914, PMID 23652522, PMID 23796235, PMID 23963131, PMID 24011548, PMID 24127770, PMID 24151551, PMID 24370612, PMID 24838360, PMID 24903195, PMID 25313879, PMID 25390695, PMID 25528363, PMID 25637294, PMID 25692257, PMID 25720332, PMID 25887027, PMID 26313170, PMID 26333723, PMID 26856213, PMID 26856228, PMID 26903338, PMID 27111533, PMID 27153945, PMID 27398737

NIH funding

2014 (3), 2009 (1), 2016 (1), 2017 (1), 2018 (1)